argenx stock sets November investor conference dates
Published on 11/06/2026 at 10:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming investor events set the agenda
- argenx management will take part in fireside chats at healthcare conferences in Boston and London.
- Investors can follow both presentations live and access replays through the company website.
- The appearances give shareholders two scheduled opportunities to hear management discuss the immunology business.
argenx has scheduled two management appearances at healthcare investor conferences in November, giving shareholders two near-term dates for updates from the immunology company. Fidelity, citing the company announcement of November 3, 2026, reported the events and the planned webcasts.
Two healthcare conferences in November
The first fireside chat is scheduled for Tuesday, November 10, at 2:00 p.m. Eastern Time during the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston. The second is set for Tuesday, November 17, at 8:30 a.m. Greenwich Mean Time at the Jefferies London Global Healthcare Conference.
Members of argenx management will participate in both sessions. The company said live webcasts will be available through its investor section, with replays remaining online for approximately 30 days after each presentation.
For investors, the appearances create scheduled opportunities to assess management commentary on the companys immunology portfolio, commercial execution and development programs. The announcement itself does not provide new financial guidance or clinical results, so the conferences represent communication dates rather than a reported change in the companys outlook.
The real-time quote of argenx stock was 796.20 euros on Lang & Schwarz at 10:37 CET on Friday, November 6, 2026.
argenx stock at a glance
- Company: argenx
- ISIN: NL0010832176
- Lang & Schwarz quote: 796.20 euros on November 6, 2026, at 10:37 CET
The broader AEX market provides the relevant European market backdrop for investors tracking Dutch-listed healthcare shares.
More news and analyses on argenx stock will follow as the scheduled investor events take place.
